Alamandine, a protective component of the renin-angiotensin system, reduces cellular proliferation and interleukin-6 secretion in human macrophages through MasR-MrgDR heteromerization

Biochem Pharmacol. 2024 Nov:229:116480. doi: 10.1016/j.bcp.2024.116480. Epub 2024 Aug 10.

Abstract

Alamandine (ALA) exerts protective effects similar to angiotensin (Ang) (1-7) through Mas-related G protein-coupled receptor type D receptor (MrgDR) activation, distinct from Mas receptor (MasR). ALA induces anti-inflammatory effects in mice but its impact in human macrophages remains unclear. We aimed to investigate the anti-inflammatory effects of ALA in human macrophages. Interleukin (IL)-6 and IL-1β were measured by ELISA in human THP-1 macrophages and human monocyte-derived macrophages exposed to lipopolysaccharide (LPS). Consequences of MasR-MrgDR heteromerization were investigated in transfected HEK293T cells. ALA decreased IL-6 and IL-1β secretion in LPS-activated THP-1 macrophages. The ALA-induced decrease in IL-6 but not in IL-1β was prevented by MasR blockade and MasR downregulation, suggesting MasR-MrgDR interaction. In human monocyte-derived M1 macrophages, ALA decreased IL-1β secretion independently of MasR. MasR-MrgDR interaction was confirmed in THP-1 macrophages, human monocyte-derived macrophages, and transfected HEK293T cells. MasR and MrgDR formed a constitutive heteromer that was not influenced by ALA. ALA promoted Akt and ERK1/2 activation only in cells expressing MasR-MrgDR heteromers, and this effect was prevented by MasR blockade. While Ang-(1-7) reduced cellular proliferation in MasR -but not MrgDR- expressing cells, ALA antiproliferative effect was elicited in cells expressing MasR-MrgDR heteromers. ALA also induced an antiproliferative response in THP-1 cells and this effect was abolished by MasR blockade, reinforcing MasR-MrgDR interaction. MasR-MrgDR heteromerization is crucial for ALA-induced anti-inflammatory and antiproliferative responses in human macrophages. This study broaden our knowledge of the protective axis of the RAS, thus enabling novel therapeutic approaches in inflammatory-associated diseases.

Keywords: Alamandine; Angiotensin-(1–7); Heteromerization; Macrophages; Mas receptor; MrgD receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Proliferation* / drug effects
  • HEK293 Cells
  • Humans
  • Interleukin-6* / metabolism
  • Macrophages* / drug effects
  • Macrophages* / metabolism
  • Oligopeptides
  • Protein Multimerization / drug effects
  • Proto-Oncogene Mas*
  • Proto-Oncogene Proteins* / metabolism
  • Receptors, G-Protein-Coupled* / metabolism
  • Renin-Angiotensin System* / drug effects
  • Renin-Angiotensin System* / physiology
  • THP-1 Cells

Substances

  • Proto-Oncogene Mas
  • Receptors, G-Protein-Coupled
  • alamandine
  • Interleukin-6
  • Proto-Oncogene Proteins
  • MRGPRD protein, human
  • IL6 protein, human
  • MAS1 protein, human
  • Oligopeptides